Greenwich LifeSciences, Inc.
GLSI
Transaktioner
286
Köp
280
Sälj
6
Nettoinsynsflöde
16.1 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
286 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-29 | Patel Snehal | CEO and CFO | Buy | 700 | 13,10 | 9 k USD |
| 2026-07-29 | Patel Snehal | CEO and CFO | Buy | 700 | 13,10 | 9 k USD |
| 2026-07-28 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,59 | 20 k USD |
| 2026-07-28 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,59 | 20 k USD |
| 2026-07-27 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,62 | 20 k USD |
| 2026-07-27 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,62 | 20 k USD |
| 2026-07-24 | Patel Snehal | CEO and CFO | Buy | 1 k | 12,88 | 14 k USD |
| 2026-07-24 | Patel Snehal | CEO and CFO | Buy | 1 k | 12,88 | 14 k USD |
| 2026-07-23 | Patel Snehal | CEO and CFO | Buy | 3 k | 13,14 | 33 k USD |
| 2026-07-23 | Patel Snehal | CEO and CFO | Buy | 3 k | 13,14 | 33 k USD |
| 2026-01-13 | Patel Snehal | CEO and CFO | Buy | 2 k | 29,83 | 54 k USD |
| 2026-01-13 | Patel Snehal | CEO and CFO | Buy | 2 k | 29,83 | 54 k USD |
| 2026-01-12 | Patel Snehal | CEO and CFO | Buy | 3 k | 27,54 | 80 k USD |
| 2026-01-12 | Patel Snehal | CEO and CFO | Buy | 3 k | 27,54 | 80 k USD |
| 2025-12-31 | Patel Snehal | CEO and CFO | Buy | 4 k | 21,36 | 92 k USD |
| 2025-12-31 | Patel Snehal | CEO and CFO | Buy | 4 k | 21,36 | 92 k USD |
| 2025-12-30 | Patel Snehal | CEO and CFO | Buy | 3 k | 21,73 | 63 k USD |
| 2025-12-30 | Patel Snehal | CEO and CFO | Buy | 3 k | 21,73 | 63 k USD |
| 2025-12-18 | Patel Snehal | CEO and CFO | Buy | 4 k | 12,62 | 52 k USD |
| 2025-12-18 | Patel Snehal | CEO and CFO | Buy | 4 k | 12,62 | 52 k USD |
| 2025-11-25 | Patel Snehal | CEO and CFO | Buy | 5 k | 8,37 | 39 k USD |
| 2025-11-25 | Patel Snehal | CEO and CFO | Buy | 5 k | 8,37 | 39 k USD |
| 2025-11-07 | Patel Snehal | CEO and CFO | Buy | 11 k | 8,43 | 89 k USD |
| 2025-11-07 | Patel Snehal | CEO and CFO | Buy | 11 k | 8,43 | 89 k USD |
| 2025-10-31 | Patel Snehal | CEO and CFO | Buy | 2 k | 9,26 | 21 k USD |
| 2025-10-31 | Patel Snehal | CEO and CFO | Buy | 2 k | 9,26 | 21 k USD |
| 2025-04-25 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,88 | 36 k USD |
| 2025-04-25 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,88 | 36 k USD |
| 2025-04-17 | Patel Snehal | CEO and CFO | Buy | 5 k | 8,98 | 48 k USD |
| 2025-04-17 | Patel Snehal | CEO and CFO | Buy | 5 k | 8,98 | 48 k USD |
| 2025-04-07 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,10 | 33 k USD |
| 2025-04-07 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,10 | 33 k USD |
| 2025-04-04 | Patel Snehal | CEO and CFO | Buy | 6 k | 8,73 | 48 k USD |
| 2025-04-04 | Patel Snehal | CEO and CFO | Buy | 6 k | 8,73 | 48 k USD |
| 2025-01-10 | Patel Snehal | CEO and CFO | Buy | 3 k | 12,51 | 31 k USD |
| 2025-01-10 | Patel Snehal | CEO and CFO | Buy | 3 k | 12,51 | 31 k USD |
| 2025-01-07 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,75 | 25 k USD |
| 2025-01-07 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,75 | 25 k USD |
| 2025-01-06 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,31 | 15 k USD |
| 2025-01-06 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,31 | 15 k USD |
| 2025-01-03 | Patel Snehal | CEO and CFO | Buy | 3 k | 12,95 | 44 k USD |
| 2025-01-03 | Patel Snehal | CEO and CFO | Buy | 3 k | 12,95 | 44 k USD |
| 2025-01-02 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,97 | 24 k USD |
| 2025-01-02 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,97 | 24 k USD |
| 2024-12-31 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,36 | 27 k USD |
| 2024-12-31 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,36 | 27 k USD |
| 2024-12-30 | Patel Snehal | CEO and CFO | Buy | 3 k | 11,12 | 36 k USD |
| 2024-12-30 | Patel Snehal | CEO and CFO | Buy | 3 k | 11,12 | 36 k USD |
| 2024-11-21 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 12,91 | 13 k USD |
| 2024-11-21 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 12,91 | 13 k USD |
| 2024-09-26 | Patel Snehal | CEO and CFO | Buy | 2 k | 14,63 | 22 k USD |
| 2024-09-26 | Patel Snehal | CEO and CFO | Buy | 2 k | 14,63 | 22 k USD |
| 2024-08-12 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 800 | 13,85 | 11 k USD |
| 2024-08-12 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 800 | 13,85 | 11 k USD |
| 2024-08-06 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,81 | 28 k USD |
| 2024-08-06 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,81 | 28 k USD |
| 2024-08-05 | Patel Snehal | CEO and CFO | Buy | 6 k | 13,18 | 72 k USD |
| 2024-08-05 | Patel Snehal | CEO and CFO | Buy | 6 k | 13,18 | 72 k USD |
| 2024-08-02 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 15,15 | 15 k USD |
| 2024-08-02 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 15,15 | 15 k USD |
| 2024-07-23 | Patel Snehal | CEO and CFO | Buy | 2 k | 15,89 | 24 k USD |
| 2024-07-23 | Patel Snehal | CEO and CFO | Buy | 2 k | 15,89 | 24 k USD |
| 2024-07-18 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 16,00 | 16 k USD |
| 2024-07-18 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 16,00 | 16 k USD |
| 2024-06-13 | Patel Snehal | CEO and CFO | Buy | 175 k | 14,30 | 2.5 mn USD |
| 2024-06-13 | Patel Snehal | CEO and CFO | Buy | 175 k | 14,30 | 2.5 mn USD |
| 2024-04-01 | Patel Snehal | CEO and CFO | Buy | 3 k | 19,08 | 57 k USD |
| 2024-04-01 | Patel Snehal | CEO and CFO | Buy | 3 k | 19,08 | 57 k USD |
| 2024-03-22 | Patel Snehal | CEO and CFO | Buy | 3 k | 19,98 | 50 k USD |
| 2024-03-22 | Patel Snehal | CEO and CFO | Buy | 3 k | 19,98 | 50 k USD |
| 2024-03-20 | Patel Snehal | CEO and CFO | Buy | 2 k | 17,68 | 27 k USD |
| 2024-03-20 | Patel Snehal | CEO and CFO | Buy | 2 k | 17,68 | 27 k USD |
| 2024-03-05 | Patel Snehal | CEO and CFO | Buy | 31 k | 12,49 | 381 k USD |
| 2024-03-05 | Patel Snehal | CEO and CFO | Buy | 31 k | 12,49 | 381 k USD |
| 2024-03-04 | Patel Snehal | CEO and CFO | Buy | 4 k | 13,03 | 53 k USD |
| 2024-03-04 | Patel Snehal | CEO and CFO | Buy | 4 k | 13,03 | 53 k USD |
| 2024-02-16 | Patel Snehal | CEO and CFO | Buy | 11 k | 11,16 | 121 k USD |
| 2024-02-16 | Patel Snehal | CEO and CFO | Buy | 11 k | 11,16 | 121 k USD |
| 2024-02-15 | Patel Snehal | CEO and CFO | Buy | 13 k | 11,07 | 141 k USD |
| 2024-02-15 | Patel Snehal | CEO and CFO | Buy | 13 k | 11,07 | 141 k USD |
| 2023-11-10 | Patel Snehal | CEO and CFO | Buy | 5 k | 10,17 | 51 k USD |
| 2023-11-10 | Patel Snehal | CEO and CFO | Buy | 5 k | 10,17 | 51 k USD |
| 2023-11-03 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,11 | 32 k USD |
| 2023-11-03 | Patel Snehal | CEO and CFO | Buy | 4 k | 9,11 | 32 k USD |
| 2023-10-27 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 8,57 | 4 k USD |
| 2023-10-27 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 8,57 | 4 k USD |
| 2023-10-26 | Patel Snehal | CEO and CFO | Buy | 3 k | 7,97 | 20 k USD |
| 2023-10-26 | Patel Snehal | CEO and CFO | Buy | 3 k | 7,97 | 20 k USD |
| 2023-10-25 | Patel Snehal | CEO and CFO | Buy | 3 k | 7,91 | 20 k USD |
| 2023-10-25 | Patel Snehal | CEO and CFO | Buy | 3 k | 7,91 | 20 k USD |
| 2023-10-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,07 | 9 k USD |
| 2023-10-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,07 | 9 k USD |
| 2023-10-04 | Patel Snehal | CEO and CFO | Buy | 2 k | 8,63 | 17 k USD |
| 2023-10-04 | Patel Snehal | CEO and CFO | Buy | 2 k | 8,63 | 17 k USD |
| 2023-09-26 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 600 | 8,71 | 5 k USD |
| 2023-09-26 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 600 | 8,71 | 5 k USD |
| 2023-09-19 | Patel Snehal | CEO and CFO | Buy | 4 k | 8,95 | 36 k USD |
| 2023-09-19 | Patel Snehal | CEO and CFO | Buy | 4 k | 8,95 | 36 k USD |
| 2023-09-11 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,48 | 9 k USD |
| 2023-09-11 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,48 | 9 k USD |
| 2023-08-22 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,97 | 10 k USD |
| 2023-08-22 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,97 | 10 k USD |
| 2023-08-04 | Patel Snehal | CEO and CFO | Buy | 2 k | 10,55 | 21 k USD |
| 2023-08-04 | Patel Snehal | CEO and CFO | Buy | 2 k | 10,55 | 21 k USD |
| 2023-07-21 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,20 | 9 k USD |
| 2023-07-21 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,20 | 9 k USD |
| 2023-07-13 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 9,49 | 2 k USD |
| 2023-07-13 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 9,49 | 2 k USD |
| 2023-05-17 | Patel Snehal | CEO and CFO | Buy | 1 k | 11,69 | 12 k USD |
| 2023-05-17 | Patel Snehal | CEO and CFO | Buy | 1 k | 11,69 | 12 k USD |
| 2023-04-28 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 11,22 | 3 k USD |
| 2023-04-28 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 11,22 | 3 k USD |
| 2023-04-19 | Patel Snehal | CEO and CFO | Buy | 7 k | 11,10 | 78 k USD |
| 2023-04-19 | Patel Snehal | CEO and CFO | Buy | 7 k | 11,10 | 78 k USD |
| 2023-04-18 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,12 | 22 k USD |
| 2023-04-18 | Patel Snehal | CEO and CFO | Buy | 2 k | 11,12 | 22 k USD |
| 2023-04-11 | Patel Snehal | CEO and CFO | Buy | 5 k | 12,42 | 62 k USD |
| 2023-04-11 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 11,87 | 12 k USD |
| 2023-04-11 | Patel Snehal | CEO and CFO | Buy | 5 k | 12,42 | 62 k USD |
| 2023-04-11 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 1 k | 11,87 | 12 k USD |
| 2023-03-15 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 12,71 | 3 k USD |
| 2023-03-15 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 12,71 | 3 k USD |
| 2023-03-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 12,12 | 12 k USD |
| 2023-03-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 12,12 | 12 k USD |
| 2023-02-24 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 15,40 | 4 k USD |
| 2023-02-24 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 15,40 | 4 k USD |
| 2023-02-17 | Patel Snehal | CEO and CFO | Buy | 600 | 16,53 | 10 k USD |
| 2023-02-17 | Patel Snehal | CEO and CFO | Buy | 600 | 16,53 | 10 k USD |
| 2023-02-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 18,68 | 19 k USD |
| 2023-02-10 | Patel Snehal | CEO and CFO | Buy | 1 k | 18,68 | 19 k USD |
| 2023-02-03 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 20,84 | 5 k USD |
| 2023-02-03 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 20,84 | 5 k USD |
| 2023-01-27 | Patel Snehal | CEO and CFO | Buy | 2 k | 19,35 | 39 k USD |
| 2023-01-27 | Patel Snehal | CEO and CFO | Buy | 2 k | 19,35 | 39 k USD |
| 2023-01-27 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 19,20 | 5 k USD |
| 2023-01-27 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 19,20 | 5 k USD |
| 2023-01-20 | Patel Snehal | CEO and CFO | Buy | 2 k | 17,37 | 26 k USD |
| 2023-01-20 | Patel Snehal | CEO and CFO | Buy | 2 k | 17,37 | 26 k USD |
| 2023-01-13 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 16,50 | 4 k USD |
| 2023-01-13 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 16,50 | 4 k USD |
| 2023-01-06 | Patel Snehal | CEO and CFO | Buy | 2 k | 15,18 | 23 k USD |
| 2023-01-06 | Patel Snehal | CEO and CFO | Buy | 2 k | 15,18 | 23 k USD |
| 2022-12-29 | Patel Snehal | CEO and CFO | Buy | 4 k | 15,19 | 61 k USD |
| 2022-12-29 | Patel Snehal | CEO and CFO | Buy | 4 k | 15,19 | 61 k USD |
| 2022-12-16 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 12,94 | 3 k USD |
| 2022-12-16 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,01 | 13 k USD |
| 2022-12-16 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,01 | 13 k USD |
| 2022-12-16 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 12,94 | 3 k USD |
| 2022-12-09 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,11 | 26 k USD |
| 2022-12-09 | Patel Snehal | CEO and CFO | Buy | 2 k | 13,11 | 26 k USD |
| 2022-12-02 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 13,98 | 3 k USD |
| 2022-12-02 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,84 | 14 k USD |
| 2022-12-02 | Patel Snehal | CEO and CFO | Buy | 1 k | 13,84 | 14 k USD |
| 2022-12-02 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 250 | 13,98 | 3 k USD |
| 2022-11-02 | Patel Snehal | CEO and CFO | Buy | 2 k | 8,79 | 18 k USD |
| 2022-11-02 | Patel Snehal | CEO and CFO | Buy | 2 k | 8,79 | 18 k USD |
| 2022-10-14 | Patel Snehal | CEO and CFO | Buy | 3 k | 9,75 | 29 k USD |
| 2022-10-14 | Patel Snehal | CEO and CFO | Buy | 3 k | 9,75 | 29 k USD |
| 2022-10-07 | Patel Snehal | CEO and CFO | Buy | 2 k | 9,72 | 19 k USD |
| 2022-10-07 | Patel Snehal | CEO and CFO | Buy | 2 k | 9,72 | 19 k USD |
| 2022-09-30 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,46 | 9 k USD |
| 2022-09-30 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,46 | 9 k USD |
| 2022-09-29 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,23 | 9 k USD |
| 2022-09-29 | Patel Snehal | CEO and CFO | Buy | 1 k | 9,23 | 9 k USD |
| 2022-06-24 | Patel Snehal | CEO and CFO | Buy | 23 k | 9,13 | 206 k USD |
| 2022-06-24 | Patel Snehal | CEO and CFO | Buy | 6 k | 9,13 | 59 k USD |
| 2022-06-24 | Patel Snehal | CEO and CFO | Buy | 23 k | 9,13 | 206 k USD |
| 2022-06-24 | Patel Snehal | CEO and CFO | Buy | 6 k | 9,13 | 59 k USD |
| 2022-06-16 | Patel Snehal | CEO and CFO | Buy | 8 k | 7,13 | 57 k USD |
| 2022-06-16 | Patel Snehal | CEO and CFO | Buy | 8 k | 7,13 | 57 k USD |
| 2022-06-14 | Patel Snehal | CEO and CFO | Buy | 12 k | 7,91 | 95 k USD |
| 2022-06-14 | Patel Snehal | CEO and CFO | Buy | 12 k | 7,91 | 95 k USD |
| 2022-06-10 | Patel Snehal | CEO and CFO | Buy | 12 k | 8,33 | 100 k USD |
| 2022-06-10 | Patel Snehal | CEO and CFO | Buy | 12 k | 8,33 | 100 k USD |
| 2022-06-09 | Patel Snehal | CEO and CFO | Buy | 5 k | 10,90 | 49 k USD |
| 2022-06-09 | Patel Snehal | CEO and CFO | Buy | 5 k | 10,90 | 49 k USD |
| 2022-06-07 | Patel Snehal | CEO and CFO | Buy | 6 k | 8,55 | 51 k USD |
| 2022-06-07 | Patel Snehal | CEO and CFO | Buy | 6 k | 8,55 | 51 k USD |
| 2022-06-03 | Patel Snehal | CEO and CFO | Buy | 9 k | 8,35 | 77 k USD |
| 2022-06-03 | Patel Snehal | CEO and CFO | Buy | 9 k | 8,35 | 77 k USD |
| 2022-06-02 | Patel Snehal | CEO and CFO | Buy | 7 k | 7,38 | 50 k USD |
| 2022-06-02 | Patel Snehal | CEO and CFO | Buy | 7 k | 7,38 | 50 k USD |
| 2022-04-25 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 16,25 | 16 k USD |
| 2022-04-25 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 16,25 | 16 k USD |
| 2022-04-21 | Patel Snehal | CEO and CFO | Buy | 6 k | 16,09 | 97 k USD |
| 2022-04-21 | Patel Snehal | CEO and CFO | Buy | 6 k | 16,09 | 97 k USD |
| 2022-04-19 | Patel Snehal | CEO and CFO | Buy | 6 k | 16,74 | 100 k USD |
| 2022-04-19 | Patel Snehal | CEO and CFO | Buy | 6 k | 16,74 | 100 k USD |
| 2022-04-19 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 16,74 | 8 k USD |
| 2022-04-19 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 16,74 | 8 k USD |
| 2022-02-11 | Patel Snehal | CEO and CFO | Buy | 6 k | 19,80 | 109 k USD |
| 2022-02-11 | Patel Snehal | CEO and CFO | Buy | 6 k | 19,80 | 109 k USD |
| 2022-02-04 | Patel Snehal | CEO and CFO | Buy | 5 k | 19,59 | 98 k USD |
| 2022-02-04 | Patel Snehal | CEO and CFO | Buy | 5 k | 19,59 | 98 k USD |
| 2022-01-31 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 18,47 | 9 k USD |
| 2022-01-31 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 18,47 | 9 k USD |
| 2022-01-21 | Hallock Kenneth | Director | Buy | 300 | 16,32 | 5 k USD |
| 2022-01-21 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 16,33 | 8 k USD |
| 2022-01-21 | Hallock Kenneth | Director | Buy | 300 | 16,32 | 5 k USD |
| 2022-01-21 | Thompson Jaye | VP Clinical Reg Affairs | Buy | 500 | 16,33 | 8 k USD |
| 2022-01-18 | Thompson Jaye | VP Clinical Reg. Affairs | Buy | 500 | 18,87 | 9 k USD |
| 2022-01-18 | Thompson Jaye | VP Clinical Reg. Affairs | Buy | 500 | 18,87 | 9 k USD |
| 2022-01-13 | Patel Snehal | CEO and CFO | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-13 | Patel Snehal | CEO and CFO | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-13 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-13 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-13 | Thompson Jaye | VP Clinical Reg. Affairs | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-13 | Thompson Jaye | VP Clinical Reg. Affairs | Buy | 1 k | 19,99 | 20 k USD |
| 2022-01-03 | Patel Snehal | CEO and CFO | Buy | 2 k | 23,82 | 49 k USD |
| 2022-01-03 | Patel Snehal | CEO and CFO | Buy | 2 k | 23,82 | 49 k USD |
| 2021-12-14 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 26,99 | 30 k USD |
| 2021-12-14 | McWilliams David | Director | Buy | 200 | 27,56 | 6 k USD |
| 2021-12-14 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 26,99 | 30 k USD |
| 2021-12-14 | Patel Snehal | CEO and CFO | Buy | 2 k | 27,17 | 50 k USD |
| 2021-12-14 | McWilliams David | Director | Buy | 200 | 27,56 | 6 k USD |
| 2021-12-14 | Patel Snehal | CEO and CFO | Buy | 2 k | 27,17 | 50 k USD |
| 2021-04-13 | Patel Snehal | CEO and CFO | Buy | 3 k | 36,98 | 100 k USD |
| 2021-04-13 | Patel Snehal | CEO and CFO | Buy | 3 k | 36,98 | 100 k USD |
| 2020-11-24 | Hallock Kenneth | Director | Buy | 1 k | 5,39 | 5 k USD |
| 2020-11-24 | Hallock Kenneth | Director | Buy | 1 k | 5,39 | 5 k USD |
| 2020-11-23 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 5,10 | 5 k USD |
| 2020-11-23 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 1 k | 5,10 | 5 k USD |
| 2020-11-20 | Rothe Eric | Director | Buy | 2 k | 5,40 | 11 k USD |
| 2020-11-20 | McWilliams David | Director | Buy | 2 k | 5,40 | 8 k USD |
| 2020-11-20 | Hallock Kenneth | Director | Buy | 1 k | 5,37 | 5 k USD |
| 2020-11-20 | Hallock Kenneth | Director | Buy | 1 k | 5,37 | 5 k USD |
| 2020-11-20 | McWilliams David | Director | Buy | 2 k | 5,40 | 8 k USD |
| 2020-11-20 | Rothe Eric | Director | Buy | 2 k | 5,40 | 11 k USD |
| 2020-11-19 | Patel Snehal | CEO and CFO | Buy | 2 k | 5,40 | 11 k USD |
| 2020-11-19 | Patel Snehal | CEO and CFO | Buy | 2 k | 5,40 | 11 k USD |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-11-10 | Patel Pankaj Amrit | 10% owner | Sell | 187 k | – | – |
| 2020-09-29 | Patel Kinnary | 10% owner | Buy | 77 k | – | – |
| 2020-09-29 | Patel Kinnary | 10% owner | Buy | 53 k | – | – |
| 2020-09-29 | Patel Kinnary | 10% owner | Buy | 77 k | – | – |
| 2020-09-29 | Patel Kinnary | 10% owner | Buy | 53 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 8 k | 4,60 | 38 k USD |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 17 k | 4,60 | 77 k USD |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 8 k | 4,60 | 38 k USD |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 17 k | 4,60 | 77 k USD |
| 2020-09-29 | McWilliams David | Director | Buy | 153 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 8 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 4 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 8 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 19 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 19 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 79 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 176 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 14 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 10 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 104 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 1.1 mn | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 3 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 34 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 50 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 77 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 53 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 19 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 19 k | – | – |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 79 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 153 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 8 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 4 k | – | – |
| 2020-09-29 | McWilliams David | Director | Buy | 8 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 176 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 14 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 10 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 104 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 1.1 mn | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 3 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 34 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 50 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 77 k | – | – |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 53 k | – | – |
| 2020-09-29 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 2 k | 5,75 | 10 k USD |
| 2020-09-29 | McWilliams David | Director | Buy | 3 k | 5,75 | 15 k USD |
| 2020-09-29 | Daugherty Frank Joseph | Chief Medical Officer | Buy | 2 k | 5,75 | 10 k USD |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 114 k | 5,75 | 657 k USD |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 75 k | 5,75 | 430 k USD |
| 2020-09-29 | Hallock Kenneth | Director | Buy | 75 k | 5,75 | 430 k USD |
| 2020-09-29 | McWilliams David | Director | Buy | 3 k | 5,75 | 15 k USD |
| 2020-09-29 | Patel Snehal | CEO and CFO | Buy | 114 k | 5,75 | 657 k USD |